These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31889633)

  • 1. Recent advances in treatment of epilepsy-related sodium channelopathies.
    Musto E; Gardella E; Møller RS
    Eur J Paediatr Neurol; 2020 Jan; 24():123-128. PubMed ID: 31889633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene variant effects across sodium channelopathies predict function and guide precision therapy.
    Brunklaus A; Feng T; Brünger T; Perez-Palma E; Heyne H; Matthews E; Semsarian C; Symonds JD; Zuberi SM; Lal D; Schorge S
    Brain; 2022 Dec; 145(12):4275-4286. PubMed ID: 35037686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium channelopathies in neurodevelopmental disorders.
    Meisler MH; Hill SF; Yu W
    Nat Rev Neurosci; 2021 Mar; 22(3):152-166. PubMed ID: 33531663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location: A surrogate for personalized treatment of sodium channelopathies.
    Holland KD; Bouley TM; Horn PS
    Ann Neurol; 2018 Jul; 84(1):1-9. PubMed ID: 30048009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Genotypes and Phenotypes of the Mutations in Voltage- Gated Sodium Channel α Subunits in Epilepsy.
    Feng Y; Zhang S; Zhang Z; Guo J; Tan Z; Zhu Y; Tao J; Ji YH
    CNS Neurol Disord Drug Targets; 2019; 18(4):266-272. PubMed ID: 30370865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage Gated Sodium Channel Genes in Epilepsy: Mutations, Functional Studies, and Treatment Dimensions.
    Ademuwagun IA; Rotimi SO; Syrbe S; Ajamma YU; Adebiyi E
    Front Neurol; 2021; 12():600050. PubMed ID: 33841294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltage-gated Sodium Channels and Blockers: An Overview and Where Will They Go?
    Li ZM; Chen LX; Li H
    Curr Med Sci; 2019 Dec; 39(6):863-873. PubMed ID: 31845216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle sodium channelopathies.
    Nicole S; Fontaine B
    Curr Opin Neurol; 2015 Oct; 28(5):508-14. PubMed ID: 26285000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying mutations in epilepsy genes: Impact on treatment selection.
    Perucca P; Perucca E
    Epilepsy Res; 2019 May; 152():18-30. PubMed ID: 30870728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy.
    Baum L; Haerian BS; Ng HK; Wong VC; Ng PW; Lui CH; Sin NC; Zhang C; Tomlinson B; Wong GW; Tan HJ; Raymond AA; Mohamed Z; Kwan P
    Hum Genet; 2014 May; 133(5):651-9. PubMed ID: 24337656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects.
    Meisler MH; O'Brien JE; Sharkey LM
    J Physiol; 2010 Jun; 588(Pt 11):1841-8. PubMed ID: 20351042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCN2A channelopathies: Mechanisms and models.
    Hedrich UBS; Lauxmann S; Lerche H
    Epilepsia; 2019 Dec; 60 Suppl 3():S68-S76. PubMed ID: 31904120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic and phenotypic characteristics of sodium channel-associated epilepsy in Chinese population.
    Dong R; Jin R; Zhang H; Zhang H; Xue M; Li Y; Zhang K; Lv Y; Li X; Liu Y; Gai Z
    J Hum Genet; 2024 Sep; 69(9):441-453. PubMed ID: 38880818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?
    Horvath GA; Demos M; Shyr C; Matthews A; Zhang L; Race S; Stockler-Ipsiroglu S; Van Allen MI; Mancarci O; Toker L; Pavlidis P; Ross CJ; Wasserman WW; Trump N; Heales S; Pope S; Cross JH; van Karnebeek CD
    Mol Genet Metab; 2016 Jan; 117(1):42-8. PubMed ID: 26647175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirming an expanded spectrum of SCN2A mutations: a case series.
    Matalon D; Goldberg E; Medne L; Marsh ED
    Epileptic Disord; 2014 Mar; 16(1):13-8. PubMed ID: 24659627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental dynamics of voltage-gated sodium channel isoform expression in the human and mouse brain.
    Liang L; Fazel Darbandi S; Pochareddy S; Gulden FO; Gilson MC; Sheppard BK; Sahagun A; An JY; Werling DM; Rubenstein JLR; Sestan N; Bender KJ; Sanders SJ
    Genome Med; 2021 Aug; 13(1):135. PubMed ID: 34425903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle and brain sodium channelopathies: genetic causes, clinical phenotypes, and management approaches.
    Matthews E; Balestrini S; Sisodiya SM; Hanna MG
    Lancet Child Adolesc Health; 2020 Jul; 4(7):536-547. PubMed ID: 32142633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
    Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
    Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on transcriptional and post-translational regulation of brain voltage-gated sodium channels.
    Onwuli DO; Beltran-Alvarez P
    Amino Acids; 2016 Mar; 48(3):641-651. PubMed ID: 26503606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insights.
    Ng AC; Chahine M; Scantlebury MH; Appendino JP
    J Neurol; 2024 Jun; 271(6):3063-3094. PubMed ID: 38607431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.